New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6942-6946

  Hendel, Houria ^a   Caillat Zucman, Sophie ^b   Lebuanec, Hélène ^a   Carrington, Mary ^c   O'Brien, Steve ^d   Andrieu, Jean Marie ^e   Schächter, François ^a   Zagury, Daniel ^a   Rappaport, Jay ^f   Winkler, Cheryl ^c   Nelson, George W ^c   Zagury, Jean François ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Hopital Laennec   (France)

^f DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA A29 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA B14 ANTIGEN; HLA B22 ANTIGEN; HLA B27 ANTIGEN; HLA B35 ANTIGEN; HLA B57 ANTIGEN; HLA C ANTIGEN; HLA C14 ANTIGEN; HLA C16 ANTIGEN; HLA C8 ANTIGEN; HLA DR ANTIGEN; HLA DR11 ANTIGEN; HLA DR4 ANTIGEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RESISTANCE; MALE; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; CHEMOKINES, CXC; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-D ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; LINKAGE DISEQUILIBRIUM; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 0033152036     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Westby, M., F. Manca, and A. G. Dalgleish. 1996. The role of host immune response in determining the outcome of HIV infection. Immunol. Today 17:120.
2. Haynes, B. F., G. Pantaleo, and A. Fauci. 1996. Toward an understanding of the correlates of protective immunity in HIV infection. Science 271:324.
3. Hill, A. V. S. 1996. HIV and HLA: confusion or complexity? Nat. Med. 2:395.
4. Akolbar, P. N., B. Gulwani-Akolbar, R. Pergolizzi, R. D. Bigler, and J. Silver. 1993. Influence of HLA genes on TCR V segment frequencies and expression levels in peripheral blood lymphocytes. J. Immunol. 150:2761.
5. Goulder, P., D. Price, M. Nowak, S. Rowland-Jones, R. Phillips, and A. McMichael. 1997. Co-evolution of HIV and cytotoxic T-lymphocytes responses. Immunol. Rev. 159:17.
6. Gaudebout, P., D. Zeliszewski, J. J. Golvano, C. Pignal, S. Le Gac, F. Borras-Cuesta, and G. Sterkers. 1997. Binding analysis of 95 HIV gp120 peptides to HLA-DR1101 and -DR0401 evidenced many HLA-class II binding regions on gp120 and suggested several promiscuous regions. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:91.
7. Atman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
8. Koenig, S., A. J. Conley, Y. A. Brewah, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. Pantaleo, J. F. Demarest, C. Carter, et al. 1995. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1:330.
9. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific CTLs during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205.
10. Goulder, P., R. E. Philips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant CTL response associated with progression to AIDS. Nat. Med. 3:212.
11. Roger, M. 1998. Influence of host genes on HIV-1 disease progression. FASEB J. 12:625.
12. Hendel, H., Y. Y. Cho, N. Gauthier, J. Rappaport, F. Schächter, and J. F. Zagury. 1996. Contribution of cohorts studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results. Biomed. Pharmacother. 50:480.
13. Malkovsky, M. 1996. HLA and natural history of HIV infection. Lancet 348:142.
14. Charron, D., ed. 1997. Genetic Diversity of HLA: Functional and Medical Implications. EDK Publisher, Sèvres, France.
15. Rappaport, J., Y. Y. Cho, H. Hendel, E. J. Schwartz, F. Schächter, and J. F. Zagury. 1997. The 32-bp CCR5 gene deletion confers resistance to fast progression among HIV-1-infected heterozygous individuals. Lancet 349:922.
16. Hendel, H., N. Henon, H. Lebuanec, A. Lachgar, H. Poncelet, S. Caillat-Zucman, C. Winkler, M. W. Smith, L. Kenefic, S. O'Brien, et al. 1998. Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms on AIDS progression. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:381.
17. Zagury, J. F., A. Still, W. Blattner, A. Lachgar, H. Lebuanec, M. Richardson, J. Rappaport, H. Hendel, B. Bizzini, A. Gringeri, et al. 1998. Antibodies to the HFV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat-toxoid as an HIV-1 vaccine. J. Hum. Virol. 1:282.
18. Steel, C. M., C. A. Ludlam, D. Beatson, J. F. Peutherer, R. J. Cuthbert, P. Simmonds, H. Morrison, and M. Jones. 1988. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1:1185.
19. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Munoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405.
20. Cruse, J. M., M. N. Brackin, R. E. Lewis, W. Meeks, R. Nolan, and B. Brackin. 1991. HLA disease association and protection in HIV infection among African Americans and Caucasians. Pathobiology 59:324.
21. Scorza-Smeraldi, R., G. Fabio, A. Lazzarin, N. B. Elisera, M. Moroni, and C. Zanussi. 1986. HLA-associated susceptibility to AIDS in Italian patients with HIV infection. Lancet 2:1187.
22. Ivanova, R., N. Henon, V. Lepage, D. Charron, E. Vicaut, and F. Schächter. 1998. HLA-DR alleles display sex-dependent effects on survival and discriminate between individual and familial longevity. Ham. Mol. Genet. 7:187.
23. Smith, M. W., M. Dean, M. Carrington, C. Winkler, G. A. Huttley, D. A. Lomb, J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R. Kaslow, et al. 1997. Contrasting influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959.
24. Winkler, C., W. Modi, M. W. Smith, G. W. Nelson, X. Wu, M. Carrington, M. Dean, T. Honjo, K. Tashiro, D. Yabe, et al. 1998. Genetic restriction of AIDS pathogenesis by an SDP1 chemokine gene variant. Science 279:389.
25. Pantaleo, G., J. F. Demarest, T. Schacker, M. Vaccarezza, O. J. Cohen, M. Daucher, C. Graziozi, S. S. Schnittman, T. C. Quinn, G. M. Shaw, et al. 1997. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. USA 94:254.
26. Donfield, S. M., H. S. Lynn, and M. W. Hilgartner. 1998. Progression to AIDS. Science 280:1819.
27. Rowland-Jones, S., R. A. Colbert, T. Dong, S. McAdam, M. Brown, K. Ariyoshi, S. Sabally, H. Whittle, and A. McMichael. 1998. Distinct recognition of closely related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and -B*2705. AIDS 12:1391.
28. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1992. Identification of overlapping HLA class I-restricted CTL epitopes in a conserved region of the HIV-1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variations. J. Exp. Med. 175:961.
29. Goulder, P. J. R., M. Bunce, P. Krausa, K. McIntype, S. Crowley, B. Morgan, A. Edwards, P. Giangrande, R. E. Philips, and A. J. McMichael. 1996. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV-1 infection. AIDS Res. Hum. Retroviruses 12:1691.
30. Klein, M. R., S. H. van der Burg, E. Hovenkamp, A. M. Holwerda, J. W. Drijhout, C. J. Melief, and F. Miedema. 1998. Characterization of HLA-B57-restricted HIV-1 Gag-and RT-specific cytotoxic T lymphocyte responses. J. Gen. Virol. 79:2191.
31. Wilson, C. C., S. A. Kalams, B. M. Wilkes, D. J. Ruhl, F. Gao, B. H. Hahn, I. C. Hanson, K. Luzuriaga, S. Wolinsky, R. Koup, et al. 1997. Overlapping epitopes in HIV-1 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J. Virol. 71:1256.
32. Tomiyama, H., K. Miwa, H. Shiga, Y. I. Moore, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Evidence of presentation of multiple HIV-1 CTL epitopes by HLA-B*3501 molecules that are associated with the accelerated progression to AIDS. J. Immimol. 158:5026.
33. Zagury, D., A. Lachgar, V. Chams, L. S. Fall, J. Bernard, J. F. Zagury, B. Bizzini, A. Gringeri, E. Santagostino, J. Rappaport, et al. 1998. IFNα and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokines decline in AIDS. Proc. Natl. Acad Sci. USA 95:385.
34. Gringeri, A., E. Santagostino, M. Muça-Perja, P. N. Mannucci, J. F. Zagury, B. Bizzini, A. Lachgar, M. Carcagno, J. Rappaport, M. Criscuolo, et al. 1998. Safety and immunogenicity of Tat-toxoid in immunocompromised HIV-1-infected patients. J. Hum. Virol. 1:293.